Adartrel 2 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

adartrel 2 mg

glaxosmithkline as - ropinirolhydroklorid - tablett, filmdrasjert - 2 mg

Audalis 60 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

audalis 60 mg

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 60 mg

Audalis 10 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

audalis 10 mg

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 10 mg

Audalis 18 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

audalis 18 mg

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 18 mg

Audalis 25 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

audalis 25 mg

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 25 mg

Audalis 40 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

audalis 40 mg

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 40 mg

Audalis 80 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

audalis 80 mg

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 80 mg

Audalis 100 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

audalis 100 mg

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 100 mg

Almogran 12.5 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

almogran 12.5 mg

almirall, s.a. - almotriptanmalat - tablett, filmdrasjert - 12.5 mg

Iasibon Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

iasibon

pharmathen s.a. - ibandronsyre - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - legemidler til behandling av bein sykdommer - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. behandling av tumor-indusert hyperkalsemi med eller uten metastaser. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.